Benatti Luca sold Quince Therapeutics, Inc. ($QNCX) shares once on the open market in the last year for a total of $173,500, with his most recent transaction on December 26, 2025. His sales rank 8,729th among 11,678 insiders, well below the average of $8.6 million across 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | Quince Therapeutics, Inc. | $QNCX | Benatti Luca | Not found | S | Common Stock | 50000 | $3.47 | 39,179.0000 | 55,681,490 | 56.07% | 0.09% |
| Oct. 23, 2024 | Quince Therapeutics, Inc. | $QNCX | Benatti Luca | Not found | J | Common Stock | 8918 | $0.00 | 89,179.0000 | 0 | 11.11% | 0.00% |
| June 4, 2025 | Quince Therapeutics, Inc. | $QNCX | Benatti Luca | Not found | A | Director Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 44,001,643 | 9999.99% | 0.06% |
| June 5, 2024 | Quince Therapeutics, Inc. | $QNCX | Benatti Luca | Not found | A | Employee Stock Option (right to buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |